July 23, 2025Nanomedicine

Carbon-based nanotechnology for Parkinson’s disease: diagnostic and therapeutic innovations

View Full Paper

Ask AI

Bookmark

Authors

ZLZainab LafiUniversity of Jordan SAS. AshaUniversity of Jordan SASara Yousef AshaUniversity of Jordan

Discussion

Member takes

Implication

This review highlights carbon-based nanomaterials' role in neuroprotection and targeted therapy in Parkinson's disease, indicating their diagnostic potential.

Key Points

Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons.
Carbon-based nanomaterials show promise in reducing oxidative stress and protecting neurons in Parkinson's disease.
CBNPs can effectively deliver drugs across the blood-brain barrier, enhancing treatment efficacy.
Despite their potential benefits, concerns about the safety and biocompatibility of CBNPs require further research.

Cite This Study

Lafi et al. (2025) studied this question.

synapsesocial.com/papers/689a0621e6551bb0af8cdc7b https://doi.org/10.1080/17435889.2025.2535940

View Full Paper

Ask AI

Bookmark

Implication

This review highlights carbon-based nanomaterials' role in neuroprotection and targeted therapy in Parkinson's disease, indicating their diagnostic potential.

Carbon-based nanotechnology for Parkinson’s disease: diagnostic and therapeutic innovations

Discussion

Member takes

Implication

Key Points

Cite This Study

Carbon-based nanotechnology for Parkinson’s disease: diagnostic and therapeutic innovations

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider